Supplements

Article
Statement of CSPI President Dr. Peter G. Lurie

Resource
Article
CSPI Cites Adulteration, Lack of Effectiveness, and Risk of Bleeding in Letter to FDA
Article
Warning Letters Follow CSPI Investigation and Request for Enforcement Action

Resource